Xutong Li

Sir Run Run Shaw Hospital — China

Computer Science · Physical Sciences

25h-index3.1kcitations114works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(48), Machine Learning in Materials Science(24), Protein Structure and Dynamics(13), Bioinformatics and Genomic Networks(9), Chemical Synthesis and Analysis(6)

Publications114 total

Dual-biomimetic Nanodecoys reprogram cardiac macrophages by suppressing STING signaling for heart repair
Journal of Controlled Release·2026Open Access
Discovery of novel selective PRMT5-MTA inhibitors through structure-based virtual screening
Bioorganic Chemistry·2025
Mechanistic Insights into the Allosteric Regulation of P53 Y220C by Small-Molecule Stabilizers
Journal of Chemical Information and Modeling·2025
MWDiff: dual-domain Mamba-Wavelet diffusion model for low-dose CT reconstruction
Biomedical Signal Processing and Control·2025
Omics-based large language models: A new engine for drug discovery innovation
Acta Pharmaceutica Sinica B·2025Open Access
Editorial: Advancing drug discovery with AI: drug–target interactions, mechanisms of action, and screening
Frontiers in Pharmacology·2025· 1 citedOpen Access
Deep Residual Learning for Molecular Force Fields
2025
SynFrag: Synthetic Accessibility Predictor based on Fragment Assembly Generation in Drug Discovery
2025Open Access
Discovery and characterization of a novel HIF-2α agonist for the treatment of CKD-related renal anemia
Acta Pharmacologica Sinica·2025Open Access
FRMA: Four-Phase Rapid Motor Adaptation Framework
Machines·2025Open Access
Deep Residual Learning for Molecular Force Fields
2025Open Access
Crayfish IMD responds rapidly to WSSV infection and the activated IMD–Relish–AMPs pathway inhibits viral replication
Fish & Shellfish Immunology·2025Open Access
Spatial-temporal evolution analysis of multi-scenario land use and ecosystem services base on PLUS-Invest model: A case study in Beijing-Tianjin-Hebei region, China
Sustainable Futures·2025· 4 citedOpen Access
Deep Residual Learning for Molecular Force Fields
2025
Deep Residual Learning for Molecular Force Fields
2025Open Access
Advancing active compound discovery for novel drug targets: insights from AI-driven approaches
Acta Pharmacologica Sinica·2025· 2 cited
Structural Optimization of Next-Generation TRK Inhibitors against Acquired Drug Resistance Mutations for the Treatment of Solid Tumors
Journal of Medicinal Chemistry·2025· 3 cited
Discovery and Identification of a Novel PORCN Inhibitor via Structure-Based Virtual Screening
ACS Chemical Biology·2025· 1 cited
Author response for "NMRExtractor: leveraging large language models to construct an experimental NMR database from open-source scientific publications"
2025
Optimizing blood-brain barrier permeability in KRAS inhibitors: A structure-constrained molecular generation approach
Journal of Pharmaceutical Analysis·2025· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Mingyue Zheng(41), Hualiang Jiang(19), Zunyun Fu(15), Dingyan Wang(14), Xiaomin Luo(14), Xiaohong Liu(13), Kaixian Chen(11), Xiaoqin Tan(11), Sulin Zhang(11), Zhaoping Xiong(10), Feisheng Zhong(10), Xiaolong Wu(9), Xiaochu Tong(9), Xiaozhe Wan(8), Zhaojun Li(8), Xiangtai Kong(8), Mingan Chen(7), Jihui Zhao(6), Xiaoyu Ding(6), Ruirui Yang(6)